Ulcerated nodular nasal basal cell carcinoma successfully treated with imiquimod 5% cream

Journal of Drugs in Dermatology

Volumn 10, Issue 3, 2011, Pages 240-241

  Cantisani, Carmen ^a   Richetta, Antonio G ^a   Balsamo, Giorgio ^a   Mattozzi, Carlo ^a   Melis, Luca ^a   Frati, Riccardo ^a   Calvieri, Stefano ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

AGED; BASAL CELL CARCINOMA; BURNING SENSATION; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DRUG EFFICACY; ERYTHEMA; FAMILY HISTORY; FEMALE; HUMAN; LETTER; SKIN EXAMINATION; SUN EXPOSURE; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR VOLUME;

AGED, 80 AND OVER; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; FEMALE; HUMANS; NOSE NEOPLASMS;

EID: 80053025857     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Bath-Hextall FJ, Perkins W, Bong J, Williams HC. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev. 2007;24:(1).
2. Sterry S, Ruzicka T, Herrera E, et al. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: Randomized studies comparing low frequency dosing with and without occlusion. Br J Dermatol. 2002;147:1227-1236. (Pubitemid 36963032)
3. Vun Y, Siller G. Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: A 3-year retrospective follow-up study. Australas J Dermatol. 2006;47(3):169-171. (Pubitemid 44015148)
4. Alessi SS, Sanches JA, De Oliveira WR, et al. Treatment of cutaneous tumors with topical 5% imiquimod cream. Clinics (Sao Paulo). 2009;64(10):961-966.
5. Gowda S, Tillman DK, Fitzpatrick JE, et al. Imiquimod-induced vitiligo after treatment of nodular basal cell carcinoma. J Cutan Pathol. 2009;36(8):878-881.